40th Annual Meeting of the Japanese Society of Neuropathology. Plenary Lecture: Clinicopathological studies on diffuse Lewy body disease

Neuropathology

Volumn 20, Issue 1, 2000, Pages 1-7

  Kosaka, Kenji ^a,b   Iseki, Eizo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

synuclein immunohistochemistry; Dementia with Lewy bodies; Diffuse Lewy body disease; Lewy body; Lewy body disease; Ubiquitin immunohistochemistry

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; DEMENTIA; DIFFUSE LEWY BODY DISEASE; EUROPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; NOMENCLATURE; NORTH AMERICA; PATHOLOGY; PRIORITY JOURNAL; WORKSHOP; BRAIN; CLASSIFICATION; LEWY BODY; REVIEW;

BRAIN; HUMANS; LEWY BODIES; LEWY BODY DISEASE; TERMINOLOGY;

EID: 0034102890     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00269.x     Document Type: Conference Paper

References (42)

1. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on CDLB International Workshop. Neurology 1996; 47: 1113-1124.
2. Yoshimura M. Cortical changes in the Parkinsonian brain: A contribution to the delineation of 'Diffuse Lewy body disease'. J Neurol 1983; 229: 17-32.
3. Kosaka K, Yoshimura M, Ikeda K, Budka M. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree. A new disease? Clin Neuropathol 1984; 3: 185-192 (this content was reported at the 9th International Congress of Neuropathology, 1982).
4. Kosaka K, Yoshimura M, Ikeda K, Budka M. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree. A new disease? Clin Neuropathol 1984; 3: 185-192 (this content was reported at the 9th International Congress of Neuropathology, 1982).
5. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204.
6. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987; 110: 1131-1153.
7. Perry RH, Irving D, Blessed G et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-139.
8. Hansen LA, Salmon D, Galasko D et al. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity. Neurology 1990; 40: 1-8.
9. Kosaka K, Iseki E, Odawara T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathology 1996; 16: 72-75.
10. Byrne EJ, Lennox G, Lowe J, Godwin-Austein RD. Diffuse Lewy body disease: Clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-717.
11. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austein RB. Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989; 52: 1236-1247.
12. Kosaka K, Oyanagi S, Matsushita M et al. Presenile dementia with Alzheimer-, Pick-, and Lewy body changes. Acta Neuropathol 1976; 36: 221-233.
13. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20: 237-244.
14. Woodard JS. Concentric hyaline inclusion body formation in mental disease. Analysis of twenty-seven cases. J Neuropathol Exp Neurol 1962; 21: 442-449.
15. Forno LS. Concentric hyaline intraneuronal inclusions of Lewy type in the brains of elderly persons (30 incidental cases); relationship to parkinsonism. J Am Geriat Soc 1969; 17: 557-575.
16. Kosaka K. Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol 1978; 42: 127-134.
17. Kosaka K, Mehraein P. Dementia-Parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 1979; 226: 241-250.
18. Forno LA, Barbour PJ, Norbille RL. Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 1978; 35: 818-822.
19. Kosaka K, Matsushita M, Oyanagi S, Mehraein P A clinicopathological study of Lewy body disease. Psychiat Neurol Japon 1980; 83: 292-311.
20. Ikeda K, Hori A, Bode G. Progressive dementia with 'diffuse Lewy-type inclusions' in cerebral cortex. Arch Psychiatr Nervenkr 1980; 228: 243-248.
21. Kosaka K. Lewy Koerperchen Krankheit: Vergleich der klinisch-pathologischen Daten zwischen Japanischen und Europaeischen/Amerikanischen Faellen (in German). 150 Jahren Psychiatrie in Deutschland 1992; 150 (Abstract).
22. Kosaka K, Iseki E. Diffuse Lewy body disease within the spectrum of Lewy body disease. In: Perry RH, McKeith I, Perry E (eds) Dementia with Lewy Bodies. Cambridge: Cambridge University Press, 1997; 238-247.
23. Kosaka K. Diffuse Lewy body disease. Inter Med 1998; 37: 6-10.
24. Kosaka K, Iseki E. Recent advances in dementia research in Japan: Non-Alzheimer-type degenerative dementias. Psychiatry Clin Neurosci 1998; 52: 367-378.
25. Kosaka K. Lewy body disease and dementia. Adv Neurol 1993; 60: 456-463.
26. Sage JI, Mark MH. Diffuse Lewy body disease. In: Stern MB, Koller WC (eds) Parkinsonian Syndromes. New York: Marcel Dekker, 1993; 393-411.
27. Gibb MRG, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: Clinical features and classification. J Neurol Neurosurg Psychiatry 1989; 52: 185-192.
28. Mark MH, Sage JI, Dickson DW, Schwarz KD, Duvoisin RC. Levodopa-nonresponsive Lewy body parkinsonism: Clinicopathologic study of two cases. Neurology 1992; 42: 1323-1327.
29. Perry RH, McKeith I, Perry E. Dementia with Lewy Bodies. Cambridge: Cambridge University Press, 1997.
30. Iseki E, Odawara T, Suzuki K et al. A pathological study of Lewy body and senile changes in the amygdala in diffuse Lewy body disease. Neuropathology 1995; 15: 112-116.
31. Dickson DW, Wertkin A, Kress Y et al. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 1990; 63: 87-99.
32. Iseki E, Odawara T, Kosaka K et al. Age-related ubiquitin-positive granular structures in non-demented subjects and neurodegenerative disorders. J Neurol Sci 1996; 142: 25-29.
33. Iseki E, Li F, Kosaka K. Close relationship between spongiform change and ubiquitin-positive neuritic structures in diffuse Lewy body disease. J Neurol Sci 1997; 146: 53-57.
34. Dickson DW, Ruan D, Crystal H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurology 1991; 41: 1402-1409.
35. Dickson DW, Schmidt ML, Lee VM-Y et al. Immunoreactive profile of hippocampal CA2-3 neurites in diffuse Lewy body disease. Acta Neuropathol 1994; 87: 269-276.
36. Iseki E, Li F, Odawara T et al. Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohisto-chemistry. J Neurol Sci 1997; 149: 165-169.
37. Hansen LA, Masiliah E, Terry RD, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 1989; 78: 194-201.
38. Baba M, Nakajo S, Tu P-H et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879-884.
39. Takeda A, Mallory M, Sundosmo M et al. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998; 152: 367-372.
40. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998; 245: 180-182.
41. Iseki E, Marui W, Kosaka K et al. Degenerative terminals of the perforant pathway human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 1998; 258: 81-84.
42. Iseki E, Marui W, Kosaka K et al. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 1999; 265: 9-12.